Kukje Pharma Co Ltd (002720) — Cash Flow Quality Index
Kukje Pharma Co Ltd (002720) has a Cash Flow Quality Index of 2.61x as of September 2025. Operating cash flow of ₩4.99 Billion exceeds net income of ₩1.91 Billion, indicating high earnings quality where cash backs reported profits. Explore how well can Kukje Pharma Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kukje Pharma Co Ltd Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Kukje Pharma Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Kukje Pharma Co Ltd (002720) cash conversion ratio.
Annual Cash Flow Quality Index for Kukje Pharma Co Ltd (2011–2024)
Year-by-year earnings quality comparison for Kukje Pharma Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.76x | ₩3.94 Billion | ₩5.21 Billion | ▼ -58.6% |
| 2022 | 1.83x | ₩6.50 Billion | ₩3.56 Billion | ▼ -21.0% |
| 2020 | 2.32x | ₩5.10 Billion | ₩2.20 Billion | ▼ -61.7% |
| 2018 | 6.04x | ₩13.25 Billion | ₩2.19 Billion | ▲ +739.6% |
| 2017 | 0.72x | ₩786.10 Million | ₩1.09 Billion | ▼ -96.5% |
| 2016 | 20.82x | ₩16.10 Billion | ₩773.06 Million | ▲ +857.6% |
| 2013 | -2.75x | ₩-4.60 Billion | ₩1.67 Billion | ▼ -114.7% |
| 2011 | 18.74x | ₩17.39 Billion | ₩927.81 Million | — |